市場調査レポート

商品コード

1562483

組織診断の市場規模、シェア、成長分析、製品タイプ別、技術別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Tissue Diagnostics Market Size, Share, Growth Analysis, By Product, By Technology, By Disease Type, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年09月09日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

組織診断の世界市場規模は2022年に51億7,000万米ドルと評価され、2023年の56億米ドルから2031年には106億8,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.4％で成長する見通しです。

世界の組織診断市場は、慢性疾患、特にがんの有病率の増加により堅調な成長を遂げています。組織診断は細胞レベルの異常を特定する重要なプロセスであり、がんやその他の疾患を正確に診断するために不可欠です。早期診断の利点に対する意識の高まりに後押しされた疾病の早期発見に対する需要の高まりが、市場の拡大を後押ししています。主要企業は、診断の正確さとスピードを向上させるため、自動化やデジタル病理診断などの技術的進歩に注力しています。加えて、ヘルスケア支出の増加、研究開発への投資、先端診断技術の統合が市場成長をさらに後押ししています。試薬や抗体を含む消耗品は、診断手順で繰り返し使用されるため、依然として主要な製品分野となっています。精密医療と個別化治療がより広く採用され、高度な診断ツールが必要とされるようになるにつれ、市場は継続的に成長するものと思われます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

F. Hoffmann-La Roche Ltd.（Switzerland）
Danaher Corporation（US）
PHC Holdings Corporation（Japan）
Thermo Fisher Scientific Inc.（US）
Abbott（US）
Agilent Technologies, Inc.（US）
Merck KGaA（Germany）
Sakura Finetek Japan Co., Ltd.（Japan）
Abcam Plc（UK）
Becton, Dickinson and Company（US）
Bio SB（US）
BioGenex（US）
Cell Signaling Technology, Inc.（US）
Histo-Line Laboratories（Italy）
Slee Medical GmbH（Germany）
CellPath Ltd.（UK）
Amos Scientific Pty Ltd.（Australia）
Jinhua Yidi Medical Appliance Co., Ltd.（China）
Medite Medical GmbH（Germany）
Diapath S.p.A.（Italy）

Product Code: SQMIG35H2161

Global Tissue Diagnostics Market size was valued at USD 5.17 billion in 2022 and is poised to grow from USD 5.60 billion in 2023 to USD 10.68 billion by 2031, growing at a CAGR of 8.4% in the forecast period (2024-2031).

Global tissue diagnostics market is experiencing robust growth due to the increasing prevalence of chronic diseases, particularly cancer. Tissue diagnostics is a critical process in identifying abnormalities at the cellular level, which is essential for diagnosing cancers and other conditions accurately. The rising demand for early detection of diseases, driven by a growing awareness of the benefits of early diagnosis, is propelling market expansion. Key players are focusing on technological advancements, such as automation and digital pathology, to improve diagnostic accuracy and speed. In addition, increasing healthcare expenditure, investments in research and development, and the integration of advanced diagnostic technologies are further driving market growth. Consumables, including reagents and antibodies, remain a dominant product segment due to their recurring usage in diagnostic procedures. The market is poised for continued growth as precision medicine and personalized treatments become more widely adopted, necessitating advanced diagnostic tools.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tissue Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tissue Diagnostics Market Segmental Analysis

Global Tissue Diagnostics Market is segmented on the basis of product, technology, disease type, end user, and region. By product, market is segmented into consumables, and instruments. By technology, market is segmented into immunohistochemistry, in situ hybridization, digital pathology & workflow management, and special staining. By disease type, market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other disease types. By end user, market is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Tissue Diagnostics Market

The growing incidence of cancer is a significant driver in the tissue diagnostics market. As cancer remains one of the leading causes of death globally, the demand for accurate and early diagnostic tools has surged. Tissue diagnostics, through techniques like immunohistochemistry (IHC) and in-situ hybridization (ISH), provides detailed insights into tumor morphology and biomarkers. These techniques help in determining the most effective treatment plans for patients, making tissue diagnostics indispensable in cancer care. As awareness of cancer screening increases, and governments and private institutions push for earlier diagnosis and treatment, the adoption of tissue diagnostic tools is expected to rise significantly. The integration of molecular diagnostics with tissue-based techniques is further enhancing the precision of these tests, supporting their use in cancer diagnosis and treatment planning.

Restraints in the Tissue Diagnostics Market

A major restraint in the tissue diagnostics market is the high cost associated with advanced diagnostic procedures. Techniques like immunohistochemistry (IHC) and next-generation sequencing (NGS) require specialized equipment and consumables, which can be costly for healthcare providers. This financial barrier limits the accessibility of these advanced diagnostic solutions, particularly in low- and middle-income regions. Additionally, the lack of adequate reimbursement policies for tissue diagnostics in certain healthcare systems further complicates the situation, discouraging hospitals and diagnostic centers from adopting the latest technologies. These high costs also pose challenges to patients, making it difficult for them to afford critical diagnostic tests, especially in regions where healthcare infrastructure is underdeveloped.

Market Trends of the Tissue Diagnostics Market

The adoption of digital pathology is a significant trend shaping the future of the tissue diagnostics market. Digital pathology involves scanning and digitizing tissue samples, enabling remote analysis, storage, and sharing among pathologists. This technology improves the efficiency of diagnostics, as it allows pathologists to access and interpret data from anywhere in the world, facilitating faster diagnosis. The integration of artificial intelligence (AI) and machine learning into digital pathology is enhancing diagnostic accuracy and helping to detect minute abnormalities that might be missed by the human eye. AI-powered systems are also aiding in the automation of routine diagnostics, reducing workload and improving the speed of analysis. As the adoption of digital pathology accelerates, it is expected to revolutionize the tissue diagnostics market by making diagnostics more accessible, efficient, and accurate.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Top Investment Analysis
Key Success Factor
Degree of Competition
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Trade Analysis

Tissue Diagnostics Market by Product

Market Overview
Consumables
- Antibodies
- Kits
- Reagents
- Probes
Instruments
- Slide-Staining Systems
- Scanners
- Tissue-Processing Systems
- Other Instruments

Tissue Diagnostics Market by Technology

Market Overview
Immunohistochemistry
In Situ Hybridization
Digital Pathology & Workflow Management
Special Staining

Tissue Diagnostics Market by Disease Type

Market Overview
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Other Disease Types

Tissue Diagnostics Market by End User

Market Overview
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other End Users

Tissue Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sakura Finetek Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio SB (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Histo-Line Laboratories (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Slee Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellPath Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amos Scientific Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinhua Yidi Medical Appliance Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medite Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diapath S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

組織診断の市場規模、シェア、成長分析、製品タイプ別、技術別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Tissue Diagnostics Market Size, Share, Growth Analysis, By Product, By Technology, By Disease Type, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

組織診断市場：製品別

組織診断市場：技術別

組織診断市場：疾患タイプ別

組織診断市場：エンドユーザー別

組織診断市場規模：地域別